CBD Nanoparticles Restore Gut-Brain-Bone Axis in Stressed Rats, Matching or Exceeding Standard Antidepressants
CBD-loaded lipid nanoparticles restored gut barrier function, normalized inflammatory markers, improved bile acid and SCFA levels, and reduced brain microglial activation in chronically stressed rats, performing comparably to atomoxetine and escitalopram.
Quick Facts
What This Study Found
Stressed rats showed 2.03-fold increase in IL-6, 1.89-fold TNF-alpha, decreased BDNF and osteocalcin, and disrupted gut metabolites (SCFAs dropped from 155.3 to 94.83 umol/L). CBD/LNP restored gut barrier (1.15-1.61-fold improvement), normalized bile acids (1.0-1.38-fold), osteocalcin (1.0-1.28-fold), and reduced glial activation (0.63-1.12-fold). All treatments corrected SCFA and polyamine levels.
Key Numbers
IL-6: 2.03-fold stress increase; SCFAs: dropped from 155.3 to 94.83 umol/L; gut barrier improved 1.15-1.61-fold with CBD/LNP; glial activation reduced to 0.63-1.12-fold.
How They Did This
Male rats exposed to repeated restraint stress, then treated with atomoxetine, escitalopram, CBD, or CBD-loaded lipid nanoparticles. Outcomes: inflammatory markers, gut metabolites, gut barrier function, microglial activation, synaptic plasticity, histology.
Why This Research Matters
This study positions CBD not just as a mental health intervention but as a multi-system therapy addressing the gut-brain-bone axis disrupted by chronic stress. The nanoparticle formulation addresses CBD bioavailability limitations.
The Bigger Picture
Chronic stress disorders involve interconnected gut, brain, and metabolic dysfunction. CBD nanoparticles addressing multiple axes simultaneously could be more effective than single-target drugs, though human translation remains distant.
What This Study Doesn't Tell Us
Animal model. Male rats only. Nanoparticle formulation adds complexity. Multiple comparisons without clear correction. Short treatment period.
Questions This Raises
- ?Do CBD nanoparticles outperform standard CBD formulations in humans?
- ?Would female rats show similar gut-brain-bone responses?
Trust & Context
- Key Stat:
- SCFAs dropped from 155.3 to 94.83 umol/L under stress, restored by CBD/LNP
- Evidence Grade:
- Comprehensive multi-system assessment with multiple treatment comparisons, but animal model limits clinical translation.
- Study Age:
- 2025 animal study comparing CBD nanoparticles to standard psychiatric medications.
- Original Title:
- Cannabidiol Lipid Nanoparticles Stabilize Gut-Brain-Bone Axis Integrity and Enhance Neuroplasticity in Stressed Rats: A Comparison with Atomoxetine and Escitalopram.
- Published In:
- International journal of molecular sciences, 26(19) (2025)
- Authors:
- Lapmanee, Sarawut, Lumsutti, Jitpatima, Charoenphon, Natthawut, Inchan, Anjaree, Boonmuen, Nittaya, Wongchitrat, Prapimpun, Thonapan, Natchayaporn, Yuajit, Chaowalit, Surinlert, Piyaporn, Tipbunjong, Chittipong, Khongkow, Mattaka, Namdee, Katawut, Sirithanakorn, Chaiyos
- Database ID:
- RTHC-06897
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Can CBD help with stress-related gut problems?
In rats, CBD nanoparticles restored gut barrier function and normalized gut metabolites disrupted by chronic stress, performing comparably to standard antidepressants.
What are CBD nanoparticles?
Lipid nanoparticles are tiny carriers that improve CBD absorption and delivery. In this study, they enhanced CBD effects on the gut-brain-bone axis.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-06897APA
Lapmanee, Sarawut; Lumsutti, Jitpatima; Charoenphon, Natthawut; Inchan, Anjaree; Boonmuen, Nittaya; Wongchitrat, Prapimpun; Thonapan, Natchayaporn; Yuajit, Chaowalit; Surinlert, Piyaporn; Tipbunjong, Chittipong; Khongkow, Mattaka; Namdee, Katawut; Sirithanakorn, Chaiyos. (2025). Cannabidiol Lipid Nanoparticles Stabilize Gut-Brain-Bone Axis Integrity and Enhance Neuroplasticity in Stressed Rats: A Comparison with Atomoxetine and Escitalopram.. International journal of molecular sciences, 26(19). https://doi.org/10.3390/ijms26199318
MLA
Lapmanee, Sarawut, et al. "Cannabidiol Lipid Nanoparticles Stabilize Gut-Brain-Bone Axis Integrity and Enhance Neuroplasticity in Stressed Rats: A Comparison with Atomoxetine and Escitalopram.." International journal of molecular sciences, 2025. https://doi.org/10.3390/ijms26199318
RethinkTHC
RethinkTHC Research Database. "Cannabidiol Lipid Nanoparticles Stabilize Gut-Brain-Bone Axi..." RTHC-06897. Retrieved from https://rethinkthc.com/research/lapmanee-2025-cannabidiol-lipid-nanoparticles-stabilize
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.